in vitro bioequivalence testing for topical ophthalmic suspension products (17of39) complex generics
Published 4 years ago • 3.3K plays • Length 19:46Download video MP4
Download video MP3
Similar videos
-
22:55
product quality testing for topical ophthalmic suspension products (18of39) complex generics 2018
-
21:09
in vitro release testing for complex generics: a bioequivalence perspective
-
8:41
in vitro release testing of complex formulations (11of39) complex generics 2018
-
1:57:52
complex generics: topical products, part 1
-
55:11
in vitro bioequivalence testing of topical generic products
-
23:51
bioequivalence for generic topical and transdermal (6of35) complex generics– sep. 25-26, 2019
-
17:59
product development considerations for generic topical products (22of39) complex generics 2018
-
1:31:52
complex generics: topical products, part 2
-
20:45
in vitro bioequivalence studies of topical drug products: challenges and promises of ivrt and ivpt
-
21:11
developing and implementing science-based standards in bioequivalence assessment
-
19:32
assessment of complex drug product – physicochemical characteristics to support in vitro be studies
-
20:11
topical dosage forms: emerging insights and implications for bioequivalence approaches
-
15:59
overview of current science-based regulatory standards (21of39) complex generics 2018
-
30:26
in vitro and in vivo abuse deterrence evaluation of generic opioids (30of39) complex generics 2018
-
25:59
fda’s inactive ingredient database (iid) (3of35) complex generics – sep. 25-26, 2019
-
1:25:59
complex generics: complex injectables, ophthalmic, and otic products, part 1
-
19:39
strategies for generic topical product development (7of35) complex generics– sep. 25-26, 2019
-
19:10
product-specific guidances for complex generic drugs
-
19:20
review of clinical endpoint bioequivalence studies in andas (17/28) generic drugs forum 2017